{"transactions":[{"id":3384,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:12.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":4221,"price":19.1131,"value":80676.3951,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":169628,"source":{"system":"sec-edgar","filing":"0002051384-26-000009","document":"form4-09032026_060906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000009/form4-09032026_060906.xml","form_type":"4"}},{"id":752359,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:11.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":4222,"price":12.6071,"value":53227.1762,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":173849,"source":{"system":"sec-edgar","filing":"0002051384-26-000006","document":"form4-06032026_060605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000006/form4-06032026_060605.xml","form_type":"4"}},{"id":842074,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T23:55:04.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1025,"price":29.3359,"value":30069.2975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":178071,"source":{"system":"sec-edgar","filing":"0002051384-26-000003","document":"form4-03162026_070301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000003/form4-03162026_070301.xml","form_type":"4"}},{"id":844302,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:20.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":91520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":91520,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":91520},"source":{"system":"sec-edgar","filing":"0002051384-26-000002","document":"form4a-03132026_040312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000002/form4a-03132026_040312.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":868998,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:12.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":58749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":58749,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":58749},"source":{"system":"sec-edgar","filing":"0002051384-26-000001","document":"form4-03032026_060308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000001/form4-03032026_060308.xml","form_type":"4"}},{"id":868997,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:12.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1026,"price":12.3616,"value":12683.0016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":179096,"source":{"system":"sec-edgar","filing":"0002051384-26-000001","document":"form4-03032026_060308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000001/form4-03032026_060308.xml","form_type":"4"}},{"id":868996,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:12.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":109105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":180122,"source":{"system":"sec-edgar","filing":"0002051384-26-000001","document":"form4-03032026_060308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000001/form4-03032026_060308.xml","form_type":"4"}},{"id":1048250,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-04T22:45:12.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":1015,"price":18.8632,"value":19146.148,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":71017,"source":{"system":"sec-edgar","filing":"0001415889-25-023745","document":"form4-09042025_060908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925023745/form4-09042025_060908.xml","form_type":"4"}},{"id":1123268,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:17.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":94,"price":18.691,"value":1756.954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":72032,"source":{"system":"sec-edgar","filing":"0001415889-25-015669","document":"form4-06042025_070614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925015669/form4-06042025_070614.xml","form_type":"4"}},{"id":1123267,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:17.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":660,"price":18.1489,"value":11978.274,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":72126,"source":{"system":"sec-edgar","filing":"0001415889-25-015669","document":"form4-06042025_070614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925015669/form4-06042025_070614.xml","form_type":"4"}},{"id":1123266,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:17.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":285,"price":17.028,"value":4852.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":72786,"source":{"system":"sec-edgar","filing":"0001415889-25-015669","document":"form4-06042025_070614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925015669/form4-06042025_070614.xml","form_type":"4"}},{"id":1236394,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-03T22:45:12.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025."}],"balance_after":52000,"derivative":{"exercise_price":19.91,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001415889-25-006233","document":"form4-03032025_050309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925006233/form4-03032025_050309.xml","form_type":"4"}},{"id":1236393,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-03T22:45:12.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":73071,"source":{"system":"sec-edgar","filing":"0001415889-25-006233","document":"form4-03032025_050309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925006233/form4-03032025_050309.xml","form_type":"4"}},{"id":1287672,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:25.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":90637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":90637,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":90637},"source":{"system":"sec-edgar","filing":"0001415889-25-002823","document":"form4-02032025_080220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925002823/form4-02032025_080220.xml","form_type":"4"}},{"id":1287671,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:25.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":53584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":53584,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":53584},"source":{"system":"sec-edgar","filing":"0001415889-25-002823","document":"form4-02032025_080220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925002823/form4-02032025_080220.xml","form_type":"4"}},{"id":1287670,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:25.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":81217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to this option shall vest one year after November 14, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":81217,"derivative":{"exercise_price":7.51,"expiration_date":"2032-12-14","underlying":"Common Stock","underlying_shares":81217},"source":{"system":"sec-edgar","filing":"0001415889-25-002823","document":"form4-02032025_080220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925002823/form4-02032025_080220.xml","form_type":"4"}},{"id":1289786,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T21:34:05.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":90637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":90637,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Class B Common Stock","underlying_shares":90637},"source":{"system":"sec-edgar","filing":"0001415889-25-002484","document":"form4-01312025_090101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000141588925002484/form4-01312025_090101.xml","form_type":"4"}}]}